Compare Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. with Similar Stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-26.42%
0%
-26.42%
6 Months
-16.43%
0%
-16.43%
1 Year
-28.22%
0%
-28.22%
2 Years
-22.52%
0%
-22.52%
3 Years
-18.18%
0%
-18.18%
4 Years
-38.1%
0%
-38.1%
5 Years
-52.63%
0%
-52.63%
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.13%
EBIT Growth (5y)
60.62%
EBIT to Interest (avg)
8.42
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0.86
Tax Ratio
19.68%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.38%
ROE (avg)
9.00%
Valuation key factors
Factor
Value
P/E Ratio
3
Industry P/E
Price to Book Value
0.32
EV to EBIT
2.03
EV to EBITDA
1.66
EV to Capital Employed
0.28
EV to Sales
0.24
PEG Ratio
NA
Dividend Yield
26.70%
ROCE (Latest)
14.01%
ROE (Latest)
10.90%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'16 - YoY
Dec'16
Dec'15
Change(%)
Net Sales
282.80
276.00
2.46%
Operating Profit (PBDIT) excl Other Income
49.60
20.20
145.54%
Interest
1.10
3.00
-63.33%
Exceptional Items
-0.40
2.40
-116.67%
Consolidate Net Profit
36.80
8.10
354.32%
Operating Profit Margin (Excl OI)
162.20%
46.70%
11.55%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2016 is 2.46% vs 28.73% in Dec 2015
Consolidated Net Profit
YoY Growth in quarter ended Dec 2016 is 354.32% vs 153.13% in Dec 2015
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,054.20
1,129.40
-6.66%
Operating Profit (PBDIT) excl Other Income
41.90
74.70
-43.91%
Interest
4.50
5.50
-18.18%
Exceptional Items
-61.80
0.00
Consolidate Net Profit
-57.60
14.90
-486.58%
Operating Profit Margin (Excl OI)
5.60%
32.90%
-2.73%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -6.66% vs -4.02% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -486.58% vs -7.45% in Dec 2024
About Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. 
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






